期刊文献+

铁缺乏症在心力衰竭中的研究进展

原文传递
导出
摘要 铁是人体必需的微量元素之一,广泛参与体内重要的代谢和生命活动,如血红蛋白和肌红蛋白对氧的运输电子转运过程、氧化磷酸化、三磷酸循环以及其他许多生物途径,是细胞能量来源的代谢必不可少的。
作者 江淑芬 王珂
出处 《内科理论与实践》 2016年第1期57-59,共3页 Journal of Internal Medicine Concepts & Practice
  • 相关文献

参考文献20

  • 1Jankowska EA, von Haehling S, Anker SD, et al. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives[J]. Eur Heart J, 2012, 34(11): 816-829.
  • 2Adlbrecht C, Kommata S, Htilsmann M, et al. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume[J]. Eur Heart J, 2008, 29(19): 2343-2350.
  • 3Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure[J]. Eur Heart J, 2010, 31(15): 1872- 1880.
  • 4周京敏,崔洁.铁缺乏症是慢性心力衰竭治疗的新目标[J].岭南心血管病杂志,2015,21(1):7-10. 被引量:11
  • 5van Veldhuisen DJ, Anker SD, Ponikowski P, et al. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches[J]. Nat Rev Cardiol, 2011, 8(9): 485-493.
  • 6van Craenenbroeck EM, Pelle A J, Beckers PJ, et al . Red cell distribution width as a marker of impaired exercise tolerance in patients with chronic heart failure[J]. Eur J Heart Fail, 2012, 14(1): 54-60.
  • 7何燕,纪蓝.铁缺乏与心力衰竭的研究进展[J].中华老年心脑血管病杂志,2012,14(7):770-771. 被引量:2
  • 8Jankowska EA, Ponikowski P. Molecular changes in myocardium in the course of anemia or iron deficiency[J]. Heart Fail Clin, 2010, 6(3): 295-304.
  • 9Dong F, Zhang X, Culver B, et al. Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration [J]. Clin Sci (Lond), 2005, 109(3): 277-286.
  • 10Naito Y, Tsujino T, Matsumoto M, et al. Adaptive response of the heart to long-term anemia induced by iron deficiency[J]. Am J Physiol Heart Circ Physiol, 2009, 296(3): H585-H593.

二级参考文献44

  • 1李利峰,张雪娥,姬富才,陈幻梅.充血性心力衰竭病人贫血患病率及其原因分析[J].中西医结合心脑血管病杂志,2007,5(10):926-927. 被引量:10
  • 2Wang W, Di X, D Agostino RB Jr, et al. Excess capacity of the iron regulatory protein system. J Biol Chem, 2007,282:24650-24659.
  • 3Harada N,Kanayama M, Maruyama A, et al. Nrf2 regulatesferroportin 1 mediated iron efflux and counteracts lipopo- lysaccharide-induced ferroportin 1 mRNA suppression in mac- rophages. Arch Biochem Biophys, 2011,508 : 101-109.
  • 4Jian W,Kostas P. Regulation of cellular iron metabolism. Bio- chem J, 2011,434 : 365-381.
  • 5Silverberg DS, Iaina A, Schwartz D, et al. Intravenous iron in heart failure: Beyond targeting anemia. Curr Heart FailRep, 2011,3:14-21.
  • 6Silverberg DS, Iaina A, Schwartz D, et al. Iron repletion in heart failure patients. Hypertension,2011,57:381-382.
  • 7Silverberg DS,Wexler D,Iaina A,et al. The role of correction of anemia in patients with congestive heart failure zA short re- view. Eur J Heart Fail,2008,9:819-823.
  • 8Anand IS. Heart failure and anemia: Mechanisms and patho physiology. Heart Fail Rev,2008,13:379-386.
  • 9Anand IS. Anemia and chronic heart failure in placation and treatment options. Am Coll Cardiol, 2008,52 : 501-511.
  • 10Anker SD,Comin Colet J, Filippatos G, et al. Ferric earboxy- maltose in patients with heart failure and iron deficiency. N Engl J Med,2009,361:2436 2448.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部